甲状腺细针穿刺:细胞病理医生审阅超声特征是否有用?
本文探讨细胞病理医生将甲状腺超声(US)审阅整合进细针穿刺诊断的意义,指出目前尚无公认的细胞学与超声特征联合报告系统,细胞病理医生若执行需要US解读专长的任务则应熟悉US解读,且不应利用US结果改变细胞学判读而不明确告知。
要点
- 目前无公认系统整合细胞学与超声特征并作为单一报告沟通。
- 细胞病理医生若执行需US解读专长的任务,应熟悉US解读。
- 不应利用US结果改变细胞学判读,除非明确沟通此行为。
核心结论
- 基于证据的整合报告系统可能比现行标准实践更有价值,使细胞病理医生能向其他医生清楚解释判读依据。
研究设计与样本
- 本文为综述,探讨将超声审阅整合进甲状腺细针穿刺诊断对执业细胞病理医生的影响。
主要发现
- 目前没有公认的系统来联合细胞学与超声特征并作为单一报告沟通结果。
- 细胞病理医生执行需要超声解读专长的任务时,应知道并完全熟悉超声解读。
- 执行穿刺的细胞病理医生是否需要超声解读专长尚不明确。
关键数值与推荐
- 细胞病理医生应避免利用超声结果改变细胞学判读,除非明确沟通此行为。
临床怎么用
- 细胞病理医生若整合超声审阅,应确保熟悉超声解读并明确沟通判读是否受超声影响。
局限性
- 原文未报告具体研究数据或系统评价结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Cytopathologist review of thyroid ultrasound (US) has been proposed to be useful in diagnosis and patient triage. This review explores the implications for practicing cytopathologists of integrating US review into the thyroid fine-needle aspiration diagnosis. At present, there is no agreed-upon system for combining cytologic and US features and communicating those results as a single report. If cytologists are performing tasks that require expertise in US interpretation, then they should know and be fully conversant with US interpretation. Whether cytologists performing aspirations require expertise in US interpretation is not clear. Regardless, cytologists should avoid using US results to alter their cytologic interpretations unless they clearly communicate that this is what they are doing. An evidence-based integrated reporting system that would allow cytologists to clearly explain to other physicians exactly how they reached their interpretation might provide value beyond current standard practice.
引用
- Renshaw AA, Gould EW, Russ G, et al. Thyroid FNA: Is cytopathologist review of ultrasound features useful? Cancer Cytopathol. 2020. PMID: 32154995. doi:10.1002/cncy.22262
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。